Clarus Therapeutics is a pharmaceutical company developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.

Register for Details

For more details on financing and valuation for Clarus Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Clarus Therapeutics's ticker symbol?

CRXT

Learn more about Clarus Therapeutics

Forge green plus iconForge green minus icon

When was Clarus Therapeutics founded?

Clarus Therapeutics was founded in 2003.
Updated on: Jun 12, 2022